ITGR vs. BAX, HOLX, GMED, MASI, TFX, ATRC, IART, ATEC, OFIX, and SRDX
Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), AtriCure (ATRC), Integra LifeSciences (IART), Alphatec (ATEC), Orthofix Medical (OFIX), and Surmodics (SRDX). These companies are all part of the "health care equipment" industry.
Integer vs.
Integer (NYSE:ITGR) and Baxter International (NYSE:BAX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, community ranking, risk and institutional ownership.
Integer has a net margin of 6.70% compared to Baxter International's net margin of 0.77%. Baxter International's return on equity of 18.30% beat Integer's return on equity.
Integer has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500.
99.3% of Integer shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Baxter International received 344 more outperform votes than Integer when rated by MarketBeat users. Likewise, 65.62% of users gave Baxter International an outperform vote while only 63.98% of users gave Integer an outperform vote.
Baxter International has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.
In the previous week, Integer had 3 more articles in the media than Baxter International. MarketBeat recorded 11 mentions for Integer and 8 mentions for Baxter International. Integer's average media sentiment score of 0.83 beat Baxter International's score of 0.51 indicating that Integer is being referred to more favorably in the media.
Integer currently has a consensus target price of $146.56, indicating a potential upside of 4.70%. Baxter International has a consensus target price of $39.44, indicating a potential upside of 28.72%. Given Baxter International's higher probable upside, analysts clearly believe Baxter International is more favorable than Integer.
Summary
Integer beats Baxter International on 11 of the 18 factors compared between the two stocks.
Get Integer News Delivered to You Automatically
Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:ITGR) was last updated on 2/19/2025 by MarketBeat.com Staff